StageZero Life Sciences Ltd T.SZLS

Way Forward

[capebretongirl]

Clearly there are questions to be answered following the CC and Financials - Cedars-Sinai, final terms of CARE closing, the 100,000 patients, Aristotle sales, revenue breakdowns etc. This one will take a while to play out as it attempts to gain traction in the covid dominated and neglected cancer detection/treatment sphere. The market is there - its just a matter of ascertaining the extent that CARE will access this market with its clinics and telehealth. We need this as covid revenue is clearly drying up.

The sp is more than disappointing -$.37 cents for a company with this revenue and cash on hand is inexplicable - clearly the market has concerns with CARE as it tanked following the April announcement - its now up to the company to show that this strategy is a winner.

We will have to continue to put up with the comedy act from the socially depraved few here who insist on trying to cause dissension.  They obviously believe Rome was built in a day.........

[davewho]

our new Director does say at the 30 min mark that they intend to cover as many patients as possible in the shortest period of time. James also said that they are ready to start booking the new rev now. I guess we will find out shortly if they are truely organised or not. I'm also still waiting to see if our analyst chimes in over the next few days.

[capebretongirl]

Unfortunately I don't think Q2 financials will prompt our analyst to change his forecast.  I believe that James also stated back in April that Aristotle was in action as he spoke.  Actual revenue improvement following the CARE deal will be the new catalyst and we will have to await a couple of quarters to find out - analyst predictions could change then.  In the interim, I doubt

[davewho]

if our analyst maintains his forecast I would see that as a good sign. Thereby giving Stage the benefit of the doubt in getting the Avrt program up and running. Aristotle actually has been somewhat in action over the past few months with patients being placed in queue on the waitlist while Care and Stage get Avrt ready. Its just the flow of rev that hasn't started until now. But like you say a

[Liked2Think]

NO call in or questions from our analyst.  If he is still an analyst for us that is. They said they didnt want to do one off tests and only record $1 now and Care record $1 separated but wait until combined so it registers as $2 for the new company.  Yeah I get it but that means they put monetary gain ahead of getting the people the help they say is important to them.  So what is